Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
89Zr-KN035 PET Imaging in PD-L1 Positive Solid Tumors
NCT04977128Unknown
- Sponsor
- The Affiliated Hospital of Jiangnan University
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Open-label, single-arm trial of 89Zr-KN035 in solid tumor, sponsored by The Affiliated Hospital of Jiangnan University. Primary endpoint: Safety of 89Zr-KN035 at 1 year. Status: unknown.
02
Drugs
89Zr-KN035
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04977128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04977128.